Abstract #0939

Predictive value of T1 mapping in cervical cancer recurrence after treatment

Jie Liu¹, Shujian Li¹, Qinchen Cao¹, Marcel Dominik Nickel², Jingliang Cheng¹, and Jinxia Zhu³

¹the First Affiliated Hospital of Zhengzhou University, Zheng zhou, China, ²MR Application Predevelopment, Siemens Healthcare GmbH, Erlangen, Germany, ³MR Collaboration, Siemens Healthineers Ltd., Beijing, China

Synopsis

We investigated the feasibility of T1-mapping to predict cervical cancer (CC) recurrence after treatment. Our results show that quantitative T1 values of the primary tumor could effectively predict the CC recurrence after surgery or concurrent chemoradiotherapy (CCRT). These findings suggest that the T1-mapping method could be valuable for evaluating CC recurrence after treatment, and native T1 values of the primary tumor could predict cervical cancer recurrence.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.